Walleye Trading
ASND icon

Walleye Trading’s Ascendis Pharma A/S ASND Stock Holding History

Walleye Trading’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.92M Buy
37,200
+8,100
+28% +$1.89M 0.01% 950
2026
Q1 		$6.66M Buy
29,100
+7,200
+33% +$1.61M 0.01% 981
2025
Q4 		$4.67M Buy
21,900
+5,400
+33% +$1.12M 0.01% 1327
2025
Q3 		$3.28M Buy
+16,500
New +$3.08M 0.01% 1491
2025
Q1 		– Sell
-4,500
Closed -$620K – 4044
2024
Q4 		$620K Buy
4,500
+3,600
+400% +$473K ﹤0.01% 2472
2024
Q3 		$134K Buy
+900
New +$122K ﹤0.01% 3211
2024
Q2 		– Sell
-2,400
Closed -$363K – 4250
2024
Q1 		$363K Sell
2,400
-400
-14% -$57.1K ﹤0.01% 3030
2023
Q4 		$353K Buy
2,800
+1,300
+87% +$130K ﹤0.01% 3374
2023
Q3 		$140K Sell
1,500
-2,300
-61% -$215K ﹤0.01% 3810
2023
Q2 		$339K Sell
3,800
-4,900
-56% -$426K ﹤0.01% 3074
2023
Q1 		$933K Buy
8,700
+1,500
+21% +$172K ﹤0.01% 2259
2022
Q4 		$879K Buy
7,200
+4,400
+157% +$511K ﹤0.01% 2320
2022
Q3 		$289K Buy
2,800
+100
+4% +$9.48K ﹤0.01% 3392
2022
Q2 		$251K Sell
2,700
-4,900
-64% -$462K ﹤0.01% 3518
2022
Q1 		$892K Buy
+7,600
New +$880K ﹤0.01% 2334
2021
Q4 		– Sell
-2,800
Closed -$446K – 5322
2021
Q3 		$446K Buy
2,800
+800
+40% +$109K ﹤0.01% 3028
2021
Q2 		$263K Buy
2,000
+300
+18% +$40K ﹤0.01% 3639
2021
Q1 		$219K Sell
1,700
-1,000
-37% -$152K ﹤0.01% 3523
2020
Q4 		$450K Buy
+2,700
New +$446K ﹤0.01% 2747

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Walleye Trading's ASND Position: Q2 2026 in Review

Walleye Trading opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 200 shares worth $53.3K. The stake represents ﹤0.01% of the portfolio and ranks #3574 among its holdings. This is a return to the name: Walleye Trading previously reported a position in ASND as recently as Q2 2025.

Walleye Trading first reported a position in ASND in Q3 2024 and has held it in 4 quarters since. The position peaked at $3.12M in Q3 2024. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Walleye Trading held 200 shares of Ascendis Pharma A/S worth $53.3K as of Q2 2026.
  • Ascendis Pharma A/S was a new Walleye Trading position in Q2 2026.
  • Ascendis Pharma A/S made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #3574 holding.
  • Walleye Trading first reported a position in Ascendis Pharma A/S in Q3 2024 and has held it in 4 quarters since.
  • Walleye Trading's Ascendis Pharma A/S position peaked at $3.12M in Q3 2024.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.